Numans Health Food Holdings Company Limited (HKG:2530)
Hong Kong · Delayed Price · Currency is HKD 0.7300
0.00 (0.00%)
Jul 30, 2026, 10:10 AM HKT
HKG:2530 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 189.34 | 277.5 | 426.55 | 367.3 | 337.61 | |
Revenue Growth | -31.77% | -34.94% | 16.13% | 8.79% | - |
Cost of Revenue | 78.02 | 67.5 | 111.11 | 117.7 | 96.92 |
Gross Profit | 111.32 | 209.99 | 315.44 | 249.59 | 240.69 |
Selling, General & Admin | 101.55 | 114.32 | 126.83 | 94.07 | 79.49 |
Other Operating Expenses | -6.97 | -14.05 | -15.9 | 52.77 | -3.75 |
Operating Expenses | 94.57 | 100.28 | 110.93 | 146.84 | 75.74 |
Operating Income | 16.75 | 109.72 | 204.51 | 102.76 | 164.95 |
Interest Expense | -0.27 | -0.26 | -0.33 | -0.38 | -0.12 |
Interest & Investment Income | 5.99 | 3.17 | 2.19 | 0.72 | 0.48 |
Currency Exchange Gain (Loss) | 0.61 | -1.24 | 1.16 | 0.05 | -0.46 |
Other Non Operating Income (Expenses) | - | - | - | -5.95 | -10.72 |
EBT Excluding Unusual Items | 23.08 | 111.39 | 207.53 | 97.2 | 154.13 |
Gain (Loss) on Sale of Assets | - | -0.01 | -0.02 | -0.09 | - |
Legal Settlements | - | 0.18 | 0.06 | 1.31 | - |
Other Unusual Items | 0.02 | -12.1 | -12.95 | - | - |
Pretax Income | 23.1 | 99.47 | 194.62 | 98.41 | 154.13 |
Income Tax Expense | 17.59 | 24.57 | 35.28 | 10.89 | 34.46 |
Net Income | 5.5 | 74.9 | 159.34 | 87.52 | 119.67 |
Net Income to Common | 5.5 | 74.9 | 159.34 | 87.52 | 119.67 |
Net Income Growth | -92.65% | -53.00% | 82.06% | -26.86% | - |
Shares Outstanding (Basic) | 993 | 750 | 750 | - | - |
Shares Outstanding (Diluted) | 993 | 750 | 750 | - | - |
Shares Change | 32.42% | - | - | - | - |
EPS (Basic) | 0.01 | 0.10 | 0.21 | - | - |
EPS (Diluted) | 0.01 | 0.10 | 0.21 | - | - |
EPS Growth | -94.45% | -53.00% | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 43.84 | 82.33 | 150.36 | 43.11 | 93 |
Free Cash Flow Per Share | 0.04 | 0.11 | 0.20 | - | - |
Dividend Per Share | 0.025 | 0.050 | - | - | - |
Dividend Growth | -50.00% | - | - | - | - |
Gross Margin | 58.79% | 75.67% | 73.95% | 67.95% | 71.29% |
Operating Margin | 8.85% | 39.54% | 47.95% | 27.98% | 48.86% |
Profit Margin | 2.91% | 26.99% | 37.36% | 23.83% | 35.45% |
Free Cash Flow Margin | 23.16% | 29.67% | 35.25% | 11.74% | 27.55% |
EBITDA | 17.54 | 110.51 | 205.9 | 104.28 | 166.38 |
EBITDA Margin | 9.26% | 39.83% | 48.27% | 28.39% | 49.28% |
D&A For EBITDA | 0.79 | 0.8 | 1.39 | 1.52 | 1.44 |
EBIT | 16.75 | 109.72 | 204.51 | 102.76 | 164.95 |
EBIT Margin | 8.85% | 39.54% | 47.95% | 27.98% | 48.86% |
Effective Tax Rate | 76.17% | 24.70% | 18.13% | 11.07% | 22.36% |
Advertising Expenses | - | - | - | 31.2 | 25.56 |